Advertisement · 728 × 90
#
Hashtag
#Trailhead_Biosystems
Advertisement · 728 × 90
Preview
Trailhead Biosystems Secures $40 Million in Expansion Financing for iPSC Innovations Trailhead Biosystems announced an additional $20 million in funding, bringing total financing to $40 million for expanding its iPSC-derived human cell products for biomedical research.

Trailhead Biosystems Secures $40 Million in Expansion Financing for iPSC Innovations #USA #Trailhead_Biosystems #Beachwood #iPSC_Technology #human_cell_models

0 0 0 0
Preview
Trailhead Biosystems Unveils New TrailBio® Hematopoietic Progenitor Cells for Research Advancements Trailhead Biosystems has launched TrailBio® hematopoietic progenitor cells derived from iPSCs, improving research in hematopoietic diseases and drug screening.

Trailhead Biosystems Unveils New TrailBio® Hematopoietic Progenitor Cells for Research Advancements #USA #Trailhead_Biosystems #Beachwood #iPSC_Technology #TrailBio

0 0 0 0
Preview
Trailhead Biosystems Expands Portfolio with New Hematopoietic Cells derived from iPSC Technology Trailhead Biosystems has launched hematopoietic progenitor cells derived from iPSCs, offering researchers a reliable tool for hematopoietic research and drug development.

Trailhead Biosystems Expands Portfolio with New Hematopoietic Cells derived from iPSC Technology #USA #Trailhead_Biosystems #Beachwood #iPSC_Technology #Hematopoietic_Cells

0 0 0 0
Preview
Trailhead Biosystems Expands iPSC-Derived Hematopoietic Progenitor Cell Portfolio Trailhead Biosystems has launched its TrailBio® hematopoietic progenitor cells, expanding its innovative iPSC-derived cell offerings for hematological research.

Trailhead Biosystems Expands iPSC-Derived Hematopoietic Progenitor Cell Portfolio #USA #Trailhead_Biosystems #Beachwood #iPSC #TrailBio

0 0 0 0
Preview
Trailhead Biosystems Launches Innovative Hematopoietic Progenitor Cells from iPSCs Trailhead Biosystems unveils TrailBio® Hematopoietic Progenitor Cells, offering researchers a consistent and scalable model for hematopoietic research.

Trailhead Biosystems Launches Innovative Hematopoietic Progenitor Cells from iPSCs #USA #Trailhead_Biosystems #Beachwood #Hematopoietic_Progenitor_Cells #iPSCs

0 0 0 0
Preview
Trailhead Biosystems Launches New TrailBio® Hematopoietic Progenitor Cells for Research Trailhead Biosystems has introduced TrailBio® Hematopoietic Progenitor Cells, which provide researchers with scalable, high-quality tools for hematopoietic studies.

Trailhead Biosystems Launches New TrailBio® Hematopoietic Progenitor Cells for Research #USA #Trailhead_Biosystems #Beachwood #iPSC #Hematopoietic_Progenitor_Cells

0 0 0 0
Preview
Trailhead Biosystems Launches Innovative A9 Dopaminergic Neurons for Parkinson's Disease Research Trailhead Biosystems has unveiled A9 Dopaminergic Neurons, an innovative tool that allows researchers to study Parkinson's disease more effectively using human models.

Trailhead Biosystems Launches Innovative A9 Dopaminergic Neurons for Parkinson's Disease Research #United_States #Parkinson's_Disease #Trailhead_Biosystems #Beachwood #A9_Neurons

0 0 0 0
Preview
Trailhead Biosystems Appoints David Llewellyn as New CEO to Lead Innovative Biotechnology Trailhead Biosystems has appointed Dr. David Llewellyn as its new CEO, succeeding Jan Jensen. His expertise aims to accelerate innovative developments in biotechnology.

Trailhead Biosystems Appoints David Llewellyn as New CEO to Lead Innovative Biotechnology #USA #Trailhead_Biosystems #David_Llewellyn #iPSC-derived_cells #Beachwood,_Ohio

0 0 0 0
Preview
Trailhead Biosystems Obtains $20 Million Funding to Propel Innovation in Biotechnology Trailhead Biosystems, focused on human cell innovation, has secured $20 million to enhance iPSC development and strengthen therapeutic partnerships, advancing drug discovery.

Trailhead Biosystems Obtains $20 Million Funding to Propel Innovation in Biotechnology #USA #regenerative_medicine #Trailhead_Biosystems #Beachwood #iPSC

0 0 0 0
Preview
Trailhead Biosystems Expands Board with Appointment of Dr. Wolfgang Hofmann Trailhead Biosystems has announced the appointment of Dr. Wolfgang Hofmann to its Board of Directors, bringing extensive experience in biotechnology and medicine.

Trailhead Biosystems Expands Board with Appointment of Dr. Wolfgang Hofmann #United_States #biotechnology #Trailhead_Biosystems #Wolfgang_Hofmann #Beachwood

0 0 0 0